Co-inhibitory proteins including cytotoxic T-lymphocyte-associated protein 4 (CLTA-4) and programmed cell death protein 1 (PD-1) are activated by binding to their ligands expressed on cancer cells [17–19]. The gene discussed is PDCD1; the disease is cancer.